文献速递银屑病与炎症性皮肤病

p75NTR与TLR4及警报素HMGB1和核磷蛋白互作:银屑病新型炎症机制

Nerve growth factor receptor p75NTR interacts with Toll-like receptor 4 and the alarmins high mobility group box 1 and nucleophosmin: a novel inflammatory mechanism in psoriasis.
PubMed 文献 · Br J Dermatol · 2026-04-17

该研究探讨p75神经营养因子受体(p75NTR)在银屑病炎症中的作用。发现银屑病患者血浆p75NTR胞外域和proNGF升高且与疾病严重度相关,p75NTR抑制可减少炎症基因表达并阻断NF-κB核转位,其机制涉及与TLR4及警报素HMGB1和核磷蛋白的相互作用。

要点

  • 银屑病患者血浆p75NTR胞外域和proNGF升高,与疾病严重度相关。
  • p75NTR抑制减少炎症基因表达并阻断NF-κB核转位。
  • p75NTR与TLR4及警报素HMGB1、核磷蛋白互作放大炎症。

核心结论

  • p75NTR上调及信号传导促进警报素释放并放大TLR4–NF-κB炎症通路,是银屑病炎症放大机制。
  • p75NTR可视为炎症传感器,为TLR4依赖炎症信号完全激活所必需。
  • 靶向p75NTR可能成为对抗银屑病慢性炎症的新治疗策略。

研究设计与样本

  • 研究纳入54例银屑病患者和25例健康供者,检测血浆proNGF和p75NTR胞外域水平。
  • 评估银屑病患者与健康供者皮肤活检及真皮成纤维细胞中p75NTR和TrkA表达。
  • 采用蛋白–蛋白相互作用分析优先筛选p75NTR潜在互作蛋白。
  • 使用LM11A-31(p75i)或RNA干扰药理抑制p75NTR,评估对细胞内信号、炎症基因表达及分子互作的影响。

主要发现

  • 银屑病斑块真皮层p75NTR表达增加,患者血浆p75NTR胞外域和proNGF水平升高并与疾病严重度相关。
  • 银屑病成纤维细胞基础p75NTR表达高,健康供者成纤维细胞中细胞因子混合液(IFN-γ、TNF-α、IL-22、IL-17A)可诱导p75NTR表达且被LM11A-31阻断。
  • 在健康供者和银屑病成纤维细胞中,p75NTR抑制显著减少细胞因子诱导的炎症基因表达并阻止NF-κB核转位;抑制TLR4可见类似效应。
  • 蛋白互作分析识别警报素HMGB1和核磷蛋白为p75NTR与TLR4间潜在连接分子,邻近连接 assay 证实其互作;细胞因子混合液增强p75NTR–TLR4–警报素互作且被p75i阻止。
  • 抑制核磷蛋白和HMGB1减少p75NTR–TLR4互作和炎症基因表达;银屑病成纤维细胞中p75NTR抑制减少细胞因子混合液或脂多糖诱导的核磷蛋白和HMGB1胞外释放。

关键数值与推荐

  • 血浆proNGF和p75NTR胞外域在54例银屑病患者与25例健康供者中检测,患者水平升高且与疾病严重度相关。
  • p75NTR抑制使用LM11A-31(p75i)或RNA干扰,显著减少炎症基因(IL6、PTGS2、CCL2、CCL20)表达。
  • TLR4抑制产生与p75NTR抑制相似的减少炎症基因表达效应。
  • 细胞因子混合液含IFN-γ、TNF-α、IL-22、IL-17A,可诱导健康供者成纤维细胞p75NTR表达并增强p75NTR–TLR4–警报素互作。

临床怎么用

  • 银屑病患者血浆p75NTR胞外域和proNGF可能作为反映疾病严重度的候选生物标志物。
  • p75NTR抑制可减少真皮成纤维细胞炎症基因表达并阻断NF-κB核转位,提示靶向p75NTR可能减轻银屑病炎症。
  • p75NTR–TLR4–警报素互作轴为银屑病慢性炎症提供潜在治疗靶点。

局限性

  • 样本量有限(54例患者和25例健康供者),需更大队列验证。
  • 研究主要基于体外成纤维细胞和活检组织,体内治疗效应尚未验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nerve growth factor (NGF) is upregulated in psoriatic skin, and increasing evidence indicates that its receptor, p75 neurotrophin receptor (p75NTR), promotes inflammatory responses. However, the contribution of p75NTR and its ligand, pro-nerve growth factor (proNGF), in psoriasis inflammation remains unclear. OBJECTIVES: To investigate the role of p75NTR in the inflammatory response of skin fibroblasts derived from plaques from patients with psoriasis, to unravel possible novel interactions. METHODS: Plasma levels of proNGF and p75NTR extracellular domain (ECD) were measured in 54 patients with psoriasis and 25 healthy donors (HDs). p75NTR and tropomyosin receptor kinase A expression were evaluated in skin biopsies and dermal fibroblasts from patients with psoriasis and from HDs. Protein–protein interaction (PPI) analysis was used to prioritize potential p75NTR interactors. The effects of cytokines related to psoriasis [interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-22, IL-17A] on receptor expression were examined in skin biopsies and fibroblasts. Pharmacological inhibition of p75NTR with LM11A-31 (p75i) or RNA interference was used to assess effects on intracellular signalling, inflammatory gene expression (IL6, PTGS2, CCL2, CCL20) and molecular interactions using reverse transcription quantitative polymerase chain reaction, Western blotting, enzyme-linked immunosorbent assay and proximity ligation assay (PLA). RESULTS: p75NTR expression was increased in the dermal layer of skin biopsies from psoriasis plaques, and plasma levels of p75NTR ECD and proNGF were enhanced in patients with psoriasis and correlated with disease severity. Psoriasis fibroblasts showed high basal p75NTR expression, which was inducible by the cytokine mix (IFN-γ, TNF-α, IL-22, IL-17A) in HD fibroblasts and blocked by LM11A-31. In fibroblasts from HDs and from patients with psoriasis, p75NTR inhibition significantly reduced cytokine-induced inflammatory gene expression and prevented nuclear translocation of nuclear factor-κB. Similar effects were seen after inhibition of Toll-like receptor 4 (TLR4). PPI analysis identified the alarmins high mobility group box 1 (HMGB1) and nucleophosmin as potential connectors between p75NTR and TLR4. These interactions were confirmed by PLA. Treatment with the cytokine mix enhanced p75NTR–TLR4–alarmin interactions, which were prevented by the p75i. Moreover, nucleophosmin and HMGB1 inhibition decreased p75NTR–TLR4 interaction and inflammatory gene expression. In psoriasis fibroblasts, p75NTR inhibition consistently reduced cytokine mix or lipopolysaccharide-induced extracellular release of nucleophosmin and HMGB1. CONCLUSION: p75NTR upregulation and signalling contribute to alarmin release and amplification of the TLR4–NF-κB inflammatory pathway in psoriasis. p75NTR can be considered a sensor of inflammation required for full activation of TLR4-dependent inflammatory signalling. Thus, p75NTR targeting may represent a novel therapeutic strategy to counteract chronic inflammation in psoriasis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Sileno S, D'Agostino M, Farina L, et al. Nerve growth factor receptor p75NTR interacts with Toll-like receptor 4 and the alarmins high mobility group box 1 and nucleophosmin: a novel inflammatory mechanism in psoriasis. Br J Dermatol. 2026. PMID: 41995608. doi:10.1093/bjd/ljag152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。